GPR55 and colorectal carcinoma: In our present study we have chosen to investigate levels of endocannabinoids, endocannabinoid-like lipids and lysophosphatidylinositol (LPI), the endogenous ligand of GPR55, in plasma of IBD and CRC patients to see whether deregulation of these metabolites is also detectable in the blood.